AIM Biotech

AIM Biotech

Biotechnology

Predictive. Scalable. At your service.

About us

AIM Biotech's platform and world-class lab services let drug researchers get more relevant, human-focused data at every stage of development. That means more informed decisions and less wasted time. Streamline your workflow. Rethink how you look at life sciences. It's time to add the human element. Mice, test tubes, and other conventional preclinical models don't truly represent the complexities of the human body. Ninety percent of potential new drugs fail in humans because of the limited insight and misleading data generated in most preclinical drug studies. AIM's plug-and-play 3D cell culture systems change all of that: by enabling the equipment you already use in your lab to mimic the human microenvironment, your research project can get more predictive data at every stage. Make more informed decisions, save time, save resources. And to help you manage it, we also offer contract research services with the prestigious Institute of Molecular and Cell Biology—so you can benefit from our unique, human-focused approach to research in a world-class laboratory.

Industry
Biotechnology
Company size
2-10 employees
Headquarters
Singapore
Type
Privately Held
Founded
2012
Specialties
3D cell culture, Microfluidics, Angiogenesis, Metastasis, Research tools, and Cell migration

Locations

Employees at AIM Biotech

Updates

Similar pages